AMY ELMS: Open Payments
NPI 1518481589 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 11 payments from 7 companies in 2025. Trend: 2023 $342 · 2024 $192 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| ABBVIE INC. | 2 | $43 |
| Tonix Medicines, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
Products named: AIRSUPRA, CAPLYTA, VRAYLAR, UBRELVY, TONMYA, KEVEYIS, Wegovy, NP Thyroid 60.
Industry payments across AR — which companies pay providers there.
